Showing results (131-140 of 149) with videos related to
Sort By:
Pageof 15
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2019
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial SpondyloarthritisAtul Deodhar, Lianne S Gensler, Jonathan Kay, et al.Clinical and Vaccine Immunology : CVI|December 26, 2014
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trialNina Wressnigg, Maikel V W van der Velden, Daniel Portsmouth, et al.Vaccine|April 7, 2015
Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trialJosefina B Cadorna-Carlos, Terry Nolan, Charissa Fay Borja-Tabora, et al.Annals of the Rheumatic Diseases|November 5, 2020
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritisRoy M Fleischmann, Ricardo Blanco, Stephen Hall, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2020
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III StudyAtul Deodhar, Ricardo Blanco, Eva Dokoupilová, et al.Journal of Colloid and Interface Science|July 15, 2026
Myelin basic protein binding is modulated by leaflet asymmetry and lipid compositionJulio M Pusterla, Alexandros Koutsioubas, Nicolò Paracini, et al.Annals of the Rheumatic Diseases|March 6, 2014
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitorArthur Kavanaugh, Philip J Mease, Juan J Gomez-Reino, et al.Annals of Internal Medicine|September 13, 2013
Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trialJoel Kremer, Zhan-Guo Li, Stephen Hall, et al.Lancet (London, England)|January 22, 2013
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trialJosef S Smolen, Peter Nash, Patrick Durez, et al.Lancet (London, England)|June 21, 2017
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trialRoy Fleischmann, Eduardo Mysler, Stephen Hall, et al.Pageof 15